1. IHME. Global Burden of Disease Collaborative Network. 2018.
2. Watkins R.R., et al. A Multicenter Survey of House Staff Knowledge About Sepsis and the "Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock". J Intensive Care Med. 35:187-190 (2020).
3. Bailey P.E., et al. Institutional maternal and perinatal deaths: a review of 40 low and middle income countries. BMC Pregnancy Childbirth.17:295 (2017).
4. Simon A.K., et al. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci.282:20143085 (2015).
5. Glaser K., & Speer C.P. Toll-like receptor signaling in neonatal sepsis and inflammation: a matter of orchestration and conditioning. Expert Rev Clin Immunol.9:1239-1252 (2013).
6. Collins A., et al. Why are preterm newborns at increased risk of infection? Arch Dis Child Fetal Neonatal Ed.103:F391-F4 (2018).
7. Tissieres P., et al. Innate immune deficiency of extremely premature neonates can be reversed by interferon-gamma. PLoS One.7:e32863 (2012).
8. Medugu N., et al. Aetiology of neonatal sepsis in Nigeria, and relevance of Group b streptococcus: A systematic review. PLoS One.13:e0200350 (2018).
9. Odorizzi P.M., & Feeney M.E. Impact of In Utero Exposure to Malaria on Fetal T Cell Immunity. Trends Mol Med.22:877-888 (2016).
10. Adatara P., et al. Risk Factors Associated with Neonatal Sepsis: A Case Study at a Specialist Hospital in Ghana. Scientific World Journal.2019:9369051 (2019).
11. Camacho-Gonzalez A., et al. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am.60:367-389 (2013).
12. Ndibazza J., et al. Associations between maternal helminth and malaria infections in pregnancy and clinical malaria in the offspring: a birth cohort in entebbe, Uganda. J Infect Dis.208:2007-2016 (2013).
13. Mpairwe H., et al.. Pregnancy and helminth infections. Parasite Immunol.36:328-337 (2014).
14. Accrombessi M., et al. Effects of Malaria in the First Trimester of Pregnancy on Poor Maternal and Birth Outcomes in Benin. Clin Infect Dis. 69(8):1385-1393 (2019).
15. Le Hesran J.Y., et al. Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life. Am J Epidemiol.146:826-831 (1997).
16. Sylvester B., et al. Prenatal exposure to Plasmodium falciparum increases frequency and shortens time from birth to first clinical malaria episodes during the first two years of life: prospective birth cohort study. Malar J. 15:379 (2016).
17. Labeaud A.D., et al. Do antenatal parasite infections devalue childhood vaccination? PLoS Negl Trop Dis. 3:e442 (2009).
18. Savas E.M., et al. Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study. Metab Syndr Relat Disord. 18(4):197-205 (2020).
19. Tzialla C., et al. New Diagnostic Possibilities for Neonatal Sepsis. Am J Perinatol. 35:575-577 (2018).
20. Meem M., et al. Biomarkers for diagnosis of neonatal infections: A systematic analysis of their potential as a point-of-care diagnostics. J Glob Health. 1:201-209 (2011).
21. Benitz W.E., et al. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics.102:E41 (1998).
22. Quadir A.F. & Britton P.N. Procalcitonin and C-reactive protein as biomarkers for neonatal bacterial infection. J Paediatr Child Health. 54:695-9 (2018).
23. Hornik C.P., et al. Use of the complete blood cell count in early-onset neonatal sepsis. Pediatr Infect Dis J. 31:799-802 (2012).
24. Elbirt D., et al. [Procalcitonin--a specific marker for severe bacterial infection and sepsis]. Harefuah. 140:343-346 (2001).
25. Alima Yanda A.N., et al. [Serum procalcitonin: a reliable tool for the diagnosis and follow-up of neonatal bacterial infections in Sub-Saharan Africa]. Arch Pediatr. 22:1015-1020 (2015).
26. Stocker M., et al. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns). Lancet. 390:871-881 (2017).
27. Lee J., et al.. The influencing factors on procalcitonin values in newborns with noninfectious conditions during the first week of life. Korean J Pediatr.60:10-16 (2017).
28. Shahkar L., et al. The role of IL-6 for predicting neonatal sepsis: a systematic review and meta-analysis. Iran J Pediatr. 21:411-417 (2011).
29. Ng P.C., et al. IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr Res. 61:93-98 (2007).
30. Wagner T.A., et al. Emerging biomarkers for the diagnosis of severe neonatal infections applicable to low resource settings. J Glob Health.1:210-23 (2011).
31. Chen H.L., et al. Plasma IP-10 as a predictor of serious bacterial infection in infants less than 4 months of age. J Trop Pediatr. 57:145-151 (2011).
32. Machado J.R., et al. Neonatal sepsis and inflammatory mediators. Mediators Inflamm. 2014:2696812014.
33. Wu H.P., et al. Serial cytokine levels in patients with severe sepsis. Inflamm Res. 58:385-393 (2009).
34. Poggi C. & Dani C. Sepsis and Oxidative Stress in the Newborn: From Pathogenesis to Novel Therapeutic Targets. Oxid Med Cell Longev. 2018:9390140 (2018).
35. Pachot A., et al. Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study. Immunol Lett. 106:63-71 (2006).
36. Tang B.M., et al. Genome-wide transcription profiling of human sepsis: a systematic review. Crit Care. 14:R237 (2010).
37. Friggeri A., et al. Decreased CX3CR1 messenger RNA expression is an independent molecular biomarker of early and late mortality in critically ill patients. Crit Care. 20:204 (2016).
38. Cazalis M.A., et al. Decreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shock. Crit Care. 17:R287 (2013).
39. Pachot A., et al. Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression. J Immunol.180:6421-29(2008).
40. Peronnet E., et al. Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections: a multicenter cohort study. Intensive Care Med.43:1013-1020 (2017).
41. Teggert A., et al. Biomarkers for Point-of-Care Diagnosis of Sepsis. Micromachines. 11(3):286 (2020).
42. Seale A.C., et al. Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. Lancet Infect Dis.9(7):428-38 (2009).
43. Djenontin A., et al. Culicidae diversity, malaria transmission and insecticide resistance alleles in malaria vectors in Ouidah-Kpomasse-Tori district from Benin (West Africa): A pre-intervention study. Parasit Vectors. 3:83 (2010).
44. Fievet N., et al. SEPSIS project: a protocol for studying biomarkers of neonatal sepsis and immune responses of infants in a malaria-endemic region. BMJ Open. 10:e036905 (2020).
45. Kuhn M., et al. Classification and Regression Training. URL https://CRAN.R-project.org/package=caret. R package version 6.0-78 (2017).
46. Gonzalez I., et al. Visualising associations between paired 'omics' data sets. BioData Min.5:19 (2012).
47. Chiesa C., et al. Early-Onset Neonatal Sepsis: Still Room for Improvement in Procalcitonin Diagnostic Accuracy Studies. Medicine.94:e1230 (2015).
48. Joram N., et al. Umbilical cord blood procalcitonin level in early neonatal infections: a 4-year university hospital cohort study. Eur J Clin Microbiol Infect Dis. 30:1005-13 (2011).
49. Lencot S., et al. A new procalcitonin cord-based algorithm in early-onset neonatal infection: for a change of paradigm. Eur J Clin Microbiol Infect Dis. 33:1229-38 (2014).
50. Altunhan H., et al. Procalcitonin measurement at 24 hours of age may be helpful in the prompt diagnosis of early-onset neonatal sepsis. Int J Infect Dis.15:e854-858 (2011).
51. Frerot A., et al. Cord blood procalcitonin level and early-onset sepsis in extremely preterm infants. Eur J Clin Microbiol Infect Dis. 38:1651-1657 (2019).
52. Mearelli F., et al. Heterogeneous models for an early discrimination between sepsis and non-infective SIRS in medical ward patients: a pilot study. Intern Emerg Med.9:749-757 (2014).
53. Ng P.C., et al. Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clin Chem. 52:1181-1189 (2006).
54. Maruoka H., et al. IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann Hematol.93:393-401(2014).
55. Wang Z.Q., et al. CD74 and intratumoral immune response in breast cancer. Oncotarget;8:12664-12674 (2017).
56. Cheng S.P., et al. CD74 expression and its therapeutic potential in thyroid carcinoma. Endocr Relat Cancer. 22:179-190 (2015).
57. Birle A., et al. Age-related low expression of HLA-DR molecules on monocytes of term and preterm newborns with and without signs of infection. J Perinatol. 23:294-299 (2003).
58. Genel F, et al. Monocyte HLA-DR expression as predictor of poor outcome in neonates with late onset neonatal sepsis. J Infect.60:224-228 (2010).
59. Palojarvi A., et al. Low monocyte HLA-DR expression as an indicator of immunodepression in very low birth weight infants. Pediatr Res. 73:469-475 (2013).
60. Pachot A., et al. Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med.33:31-38 (2005).
61. Payen D., et al. Gene profiling in human blood leucocytes during recovery from septic shock. Intensive Care Med. 34:1371-1376 (2008).
62. Fumeaux T. & Pugin J. Is the measurement of monocytes HLA-DR expression useful in patients with sepsis? Intensive Care Med. 32:1106-11078 (2006).
63. Satoh A., et al. Human leukocyte antigen-DR expression on peripheral monocytes as a predictive marker of sepsis during acute pancreatitis. Pancreas. 25:245-250 (2002).
64. Pfortmueller C.A., et al.. Assessment of immune organ dysfunction in critical illness: utility of innate immune response markers. Intensive Care Med Exp. 5:49 (2017).
65. Sundar K.M. & Sires M. Sepsis induced immunosuppression: Implications for secondary infections and complications. Indian J Crit Care Med. 17:162-169 (2013)
66. Fotopoulos F.D., et al. The monocyte HLA-DR expression of healthy and infected premature neonates. Pediatric Research. 45:763 (1999).
67. Olin A., et al. Stereotypic Immune System Development in Newborn Children. Cell. 174:1277-92 e14 (2018).
68. Smolen K.K., et al. Pattern recognition receptor-mediated cytokine response in infants across 4 continents. J Allergy Clin Immunol.133:818-26 e4(2014).
69. Ogundare E., et al. Presentation and outcomes of early and late onset neonatal sepsis in a Nigerian Hospital. Afr Health Sci. 19:2390-2399 (2019).
70. Aku F.Y., et al. Bacteriological profile and antibiotic susceptibility pattern of common isolates of neonatal sepsis, Ho Municipality, Ghana-2016. Matern Health Neonatol Perinatol. 4:2 (2018).
71. Tadesse B.T., et al. Antimicrobial resistance in Africa: a systematic review. BMC Infect Dis.; 17(1):616 (2017).
72. Mitgang E.A., et al. Review and mapping of carbapenem-resistant Enterobacteriaceae in Africa: Using diverse data to inform surveillance gaps. Int J Antimicrob Agents 52:372-84 (2018).
73. Jesumirhewe C., et al. Carbapenemase-Producing Enterobacteriaceae Isolates from Edo State, Nigeria. Antimicrob Agents Chemother.61(8): e00255-17 (2017).
74. Lester R., et al. Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review. J Antimicrob Chemother. 75:492-507 (2020)